FAIRFAX, Va., Jan. 10, 2016 (GLOBE NEWSWIRE) -- Dr. Howard Budner & Associates offers Ortho-K, an affordable, non-surgical alternative to LASIK surgery. Ortho-K, which stands for Orthokeratology, uses specially designed gas permeable contact lenses to correct myopia. Patients wear the lenses while sleeping at night. The lenses gently reshape the cornea for clearer vision the following day. Vision improvement lasts for one to two days; for best results, lenses should be worn nightly. Ortho-K lenses are primarily used to correct refractive errors for nearsightedness and astigmatism. Ortho-K is also an effective treatment option for slowing the progression of childhood myopia.
Fairfax, VA and Rockville, MD patients searching for an affordable alternative to LASIK may benefit from Ortho-K, a non-surgical, reversible treatment offered through Dr. Howard Budner & Associates. “Ortho-K is most frequently used to temporarily correct myopia, although this non-surgical treatment can also correct lesser degrees of astigmatism," said optometrist Dr. Howard Budner. “The type and amount of correction depends on the patient’s vision needs and is handled on a case-by-case basis.”
Ortho-K is a non-surgical alternative to LASIK that uses specially fitted lenses to reshape a patient’s cornea at night. Patients wear the lenses while sleeping and remove them during the day to enjoy clear vision. The lenses reshape the eye’s surface, correcting refractive errors. These changes last one to two days, says Dr. Budner, who recommends patients wear the lenses each night for maximum vision correction benefit. “Many of our patients who use Ortho-K do so because they do not feel comfortable receiving LASIK surgery but also do not want to wear glasses or contact lenses during the day,” said Dr. Budner. “Ortho-K is also a great vision correction option for individuals who play sports or have jobs that make glasses or contacts uncomfortable or difficult to wear and for children.”
Most patients achieve 20/20 vision after Ortho-K, although the legal minimum for driving (20/40) is also an acceptable outcome. An FDA study of Paragon corneal refractive therapy (CRT) lenses, a proprietary lens correction method similar to Ortho-K, found that 93 percent of patients achieved 20/32 vision or better, and 67 percent achieved 20/20 or better over a nine month period.
In addition to providing temporary vision correction, Ortho-K may also help to slow the progression of myopia in children. A 2013 study published in Eye & Contact Lens found that children wearing Ortho-K contacts showed significantly more stable myopia when compared with those who did not and 64% of cases stabilized.
Dr. Howard Budner & Associates serve patients in Rockville, Fairfax, Potomac, Mclean, Vienna, Reston, Olney and Bethesda. The eye care centers offer more than 1,000 frames in stock and full range of optometry services, including eye disease diagnosis and treatment. For more information on Ortho-K or eye care, call 703-691-8008 or visit www.drbudner.com.
Dr. Howard Budner & Associates, 703-691-8008 and 301-871-0180


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Instagram Outage Disrupts Thousands of U.S. Users
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



